论文部分内容阅读
视网膜动脉阻塞和视网膜静脉阻塞是临床上最常见的致盲眼病。近年来,随着眼科医疗设备和诊疗技术的提高,视网膜血管阻塞性疾病有了一些新疗法(如高压氧治疗、视乳头放射状切开术、视乳头穿刺术、视网膜血管外膜切开术、激光诱导脉络膜视网膜静脉吻合术、选择性动脉内溶栓、经玻璃体视网膜中央动脉插管术、经玻璃体微穿刺术、玻璃体腔注射贝伐单抗、激光光凝治疗等),给此类疾病的治疗带来新的希望,但对每种新疗法均需进一步科学、谨慎地探讨和观察随访。
Retinal artery occlusion and retinal vein occlusion are the most common causes of blindness in the clinic. In recent years, with the advancement of ophthalmic medical equipment and diagnosis and treatment techniques, there have been some new therapies for retinal vascular occlusive diseases (such as hyperbaric oxygen therapy, optic nerve radiofrequency ablation, papillae, retinal vascular adventitial incision, Laser-induced chorioretinal venous anastomosis, selective intra-arterial thrombolysis, vitreoretinal central arterial cannulation, vitreous micro-puncture, intravitreal injection of bevacizumab, laser photocoagulation, etc.), to these diseases Treatment brings new hope, but each new treatment requires further scientific, careful exploration and observation follow-up.